We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+4.34%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$13B
AUM Growth
-$115M
(-0.88%)
Cap. Flow
-$476M
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
17.73%
Holding
278
New
34
Increased
65
Reduced
136
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$163M |
| 2 |
CME Group
CME
|
+$86.1M |
| 3 |
IBM
IBM
|
+$80.3M |
| 4 |
Costco
COST
|
+$70.9M |
| 5 |
CMA
Comerica
CMA
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$110M |
| 2 |
MSCC
Microsemi Corp
MSCC
|
+$92.3M |
| 3 |
Intercontinental Exchange
ICE
|
+$90.3M |
| 4 |
Verizon
VZ
|
+$80.6M |
| 5 |
Eli Lilly
LLY
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.57% |
| 2 | Healthcare | 15.72% |
| 3 | Industrials | 14.12% |
| 4 | Financials | 12.28% |
| 5 | Consumer Discretionary | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CORV
201
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $9.73M | 0.08% |
4,192,034
-486,330
| -10% | -$769K |
|
202
Green Dot
GDOT
$759M
| $9.57M | 0.07% |
+149,190
| New | +$9.4M |
|
203
8x8 Inc
EGHT
$328M
| $9.49M | 0.07% |
+509,020
| New | +$9M |
|
|
204
Eli Lilly
LLY
$1.06T
| $8.45M | 0.07% |
109,170
-923,681
| -89% | -$74.4M |
|
205
Universal Display
OLED
$4.01B
| $8.12M | 0.06% |
+80,392
| New | +$12.1M |
|
206
Texas Instruments
TXN
$254B
| $7.98M | 0.06% |
76,830
| – | – |
|
|
ORBK
207
DELISTED
Orbotech Ltd
ORBK
| $7.96M | 0.06% |
128,094
-982,413
| -88% | -$53.9M |
|
208
JPMorgan Chase
JPM
$947B
| $7.47M | 0.06% |
67,890
+12,595
| +23% | +$1.43M |
|
209
Walmart Inc
WMT
$892B
| $7.37M | 0.06% |
248,595
-90
| -0% | -$2.9K |
|
210
Citizens Financial Group
CFG
$30.5B
| $6.63M | 0.05% |
157,820
-50
| -0% | -$2.25K |
|
211
Conagra Brands
CAG
$7.11B
| $6.61M | 0.05% |
179,085
-60
| -0% | -$2.21K |
|
212
Occidental Petroleum
OXY
$56B
| $6.32M | 0.05% |
97,215
-30
| -0% | -$2.1K |
|
213
Royal Caribbean
RCL
$85.7B
| $6.2M | 0.05% |
52,655
-20
| -0% | -$2.53K |
|
214
Thermo Fisher Scientific
TMO
$214B
| $6.18M | 0.05% |
29,923
-288
| -1% | -$60.5K |
|
215
Jack Henry & Associates
JKHY
$11.2B
| $6.1M | 0.05% |
50,419
-20
| -0% | -$2.43K |
|
|
FNGN
216
DELISTED
Financial Engines, Inc.
FNGN
| $5.51M | 0.04% |
157,580
-55
| -0% | -$1.73K |
|
|
217
Verizon
VZ
$195B
| $5.34M | 0.04% |
111,654
-1,604,393
| -93% | -$80.6M |
|
218
Johnson & Johnson
JNJ
$619B
| $5.24M | 0.04% |
+40,879
| New | +$5.53M |
|
219
Cummins
CMI
$88.7B
| $5.24M | 0.04% |
32,300
-10
| -0% | -$1.72K |
|
220
Honeywell
HON
$76.3B
| $4.76M | 0.04% |
36,459
+5,026
| +16% | +$695K |
|
221
Caterpillar
CAT
$394B
| $4.56M | 0.04% |
30,920
-11,190
| -27% | -$1.77M |
|
222
Lockheed Martin
LMT
$135B
| $4.55M | 0.04% |
13,458
-10
| -0.1% | -$3.4K |
|
223
Archer Daniels Midland
ADM
$37.4B
| $4.26M | 0.03% |
+98,260
| New | +$4.14M |
|
224
NextEra Energy
NEE
$176B
| $4.06M | 0.03% |
99,480
-40
| -0% | -$1.54K |
|
225
Danaher
DHR
$141B
| $4.06M | 0.03% |
46,739
-821,347
| -95% | -$71.8M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Westfield Capital Management held 278 positions worth $13B, down 0.88% from $13.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Westfield Capital Management withdrew a net $476M in Q1 2018, closing 30 positions and reducing 136 holdings. Its most notable exit was Intercontinental Exchange, an estimated $90.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Westfield Capital Management opened a new position in UnitedHealth worth $152M.
- Westfield Capital Management's largest Q1 2018 buy was UnitedHealth: 712,092 shares worth $152M.
- Westfield Capital Management added most to CME Group in Q1 2018, an estimated $86.1M increase.
- Westfield Capital Management's biggest Q1 2018 reduction was Nektar Therapeutics, cutting an estimated $110M.
- Westfield Capital Management fully exited Intercontinental Exchange in Q1 2018, selling an estimated $90.3M.
- Westfield Capital Management's ten largest holdings make up 18% of its $13B portfolio in Q1 2018.
- Westfield Capital Management opened 34 new positions and closed 30 in Q1 2018.
- Westfield Capital Management's portfolio value fell 0.88% quarter-over-quarter to $13B.
Based on Westfield Capital Management's 13F filing for Q1 2018, filed 14 May 2018.